BluMaiden utilizes artificial intelligence (AI) to revolutionize small-molecule drug discovery by streamlining the process of designing new drugs. By harnessing AI algorithms, BluMaiden efficiently analyzes massive amounts of data to predict how molecules will interact with biological targets, enabling the identification of potential drug candidates more quickly and accurately. This innovative approach has the potential to significantly accelerate the development of new medications and improve treatment options for various diseases.
Source link
Why e-commerce startups will revolutionise the supply chain in Southeast Asia
In response to the disruptions caused by the coronavirus pandemic, businesses in Southeast Asia are turning to diversification, such as expanding into logistics, to survive. Startups like Quincus are playing a crucial role in helping companies navigate the unique challenges of the region's supply chain. By leveraging innovation, data, and technology, startups are driving the evolution of the supply chain industry in Southeast Asia, ultimately leading to increased efficiency and resilience in the face of...
Read more